Overview of respiratory virus epidemiology in the EU/EEA, week 44, 2026
Updates for Overview of respiratory virus epidemiology in the EU/EEA, week 44, 2026
Date
Key facts
Consultation rates for respiratory illness in both primary and secondary care are slowly increasing, but remain at low or baseline levels in all reporting EU/EEA countries. SARS-CoV-2 remains the main contributor to respiratory virus activity this week, with a median test positivity of 11% in both…
Consultation rates for respiratory illness in both primary and secondary care are slowly increasing, but remain at low or baseline levels in all reporting EU/EEA countries. SARS-CoV-2 remains the main contributor to respiratory virus activity this week, with median test positivity of 11% in primary…
Consultation rates for respiratory illness in both primary and secondary care remain at low or baseline levels in all reporting EU/EEA countries. SARS-CoV-2 remains the main contributor to respiratory virus activity in primary and secondary care this week, with median test positivity of 5.2% in…
Consultation rates for respiratory illness in both primary and secondary care remain at low or baseline levels in all reporting EU/EEA countries. However, rates are increasing in many countries. Both SARS-CoV-2 and influenza are contributing to respiratory virus activity in primary and secondary…
Consultation rates for respiratory illness in both primary and secondary care remain at low or baseline levels in all reporting EU/EEA countries. However, rates are increasing in many countries, as expected at this time of year. Overall, SARS-CoV-2 and influenza contributed similarly to respiratory…
The number of patients presenting to primary care with symptoms of respiratory illness, including acute respiratory infection, remains mostly at low or baseline levels in EU/EEA countries. However, the respiratory illness consultation rates are increasing in most countries. SARS-CoV-2 test…
Consultation rates for respiratory illness in both primary and secondary care settings are increasing in some Member States, yet remain at baseline levels across all EU/EEA countries, except for Denmark and Spain, which reported low activity in primary care settings. SARS-CoV-2activity is increasing…
Consultation rates for respiratory illness in both primary and secondary care settings remain at baseline levels across most EU/EEA countries. Denmark continues to report low activity in primary care settings. SARS-CoV-2 activity is increasing slightly in primary and secondary care in several EU/EEA…
Consultation rates for respiratory illness in both primary and secondary care settings remain at baseline levels across most European Union/European Economic Area (EU/EEA) countries, with only one country reporting activity above baseline. An increase in SARS-CoV-2 circulation is still being…
Primary care consultations for respiratory illness remain at baseline levels across most EU/EEA countries, with one country reporting low activity. However, recent increases are observed in SARS-CoV-2 and influenza virus circulation. SARS-CoV-2 activity remains low overall but continues to increase…
Respiratory virus activity remains at baseline levels across EU/EEA countries reporting rates of influenza-like illness (ILI) and/or acute respiratory infection (ARI), however, increases are observed in SARS-CoV-2 and influenza virus circulation. SARS-CoV-2 activity is low but increasing in primary…
Respiratory virus activity across EU/EEA countries remains at baseline levels, indicating limited circulation of respiratory viruses. SARS-CoV-2 activity remains low across all age groups but is slowly increasing in some countries. Although numbers of hospital admissions remain very low, a few…
Respiratory virus activity across EU/EEA countries remains at baseline levels, indicating limited circulation of respiratory viruses. SARS-CoV-2 activity remains low across all age groups but is slowly increasing in some countries. Although numbers of hospital admissions remain very low, a few…
Respiratory virus activity across EU/EEA countries remains at baseline levels, indicating limited circulation of respiratory viruses. SARS-CoV-2 activity remains low across all age groups. A slight upward trend in SARS-CoV-2 activity in both primary and secondary care settings is observed across…
Respiratory virus activity across EU/EEA countries remains at baseline levels, indicating limited circulation of respiratory viruses. SARS-CoV-2 activity remains low across all age groups in both primary and secondary care settings; Both Influenza virus and Respiratory syncytial virus (RSV) activity…
Respiratory virus activity across EU/EEA countries remains at baseline levels, indicating limited circulation of respiratory viruses. SARS-CoV-2 activity remains low across all age groups in both primary and secondary care settings; Influenza virus and Respiratory syncytial virus (RSV) activity are…
Respiratory virus activity across EU/EEA countries remains at baseline levels, indicating limited respiratory virus circulation. SARS-CoV-2 activity continues to be low in all age groups in primary and secondary care. Respiratory syncytial virus (RSV) activity is low, at inter-seasonal levels…
Important: This ERVISS publication follows the recent transition of reporting surveillance data from The European Surveillance System (TESSy) to EpiPulse Cases (EPC). As a result of this transition, we have identified a few data inconsistencies. We are actively working with individual countries to…
Important: This is the second publication of ERVISS following the transition of reporting surveillance data from The European Surveillance System (TESSy), which has been decommissioned, to EpiPulse Cases (EPC). As a result of this transition, we have identified some inconsistencies in data from…
Important: This is the first publication of ERVISS following the transition of reporting surveillance data from The European Surveillance System (TESSy), which has been decommissioned, to EpiPulse Cases (EPC). As a result of this transition, we have identified some inconsistencies in data from…
Summary In week 18, the number of people reporting symptoms of viral respiratory illness is at baseline to low levels consistent with a late season/inter-seasonal situation. Respiratory syncytial virus (RSV) remains the main contributor to current respiratory virus activity, particularly for severe…
Summary In week 17, the number of people reporting symptoms of respiratory illness is at baseline to low levels and continues to decrease across the EU/EEA. Overall, respiratory virus circulation is limited. Respiratory syncytial virus (RSV) remains the main contributor to current respiratory virus…
Summary In week 16, 2026, the number of people reporting symptoms of respiratory illness is at baseline to low levels and continues to decrease across the EU/EEA. Respiratory syncytial virus (RSV) appears to be the main contributor to respiratory virus activity. Circulation is moderate but…
Summary In week 15, 2026, primary care and hospital consultations for respiratory illness were at baseline levels in all but one country, indicating low respiratory virus circulation across the EU/EEA. Influenza virus activity has returned to inter-seasonal levels in almost all countries, with low…
Summary Primary care consultations for respiratory illness are at baseline levels in most reporting countries, indicating low respiratory virus circulation across much of the EU/EEA. Influenza virus circulation and hospitalisations remain low and continue to decline across all age groups. Influenza…